Together, an extensive panel of consented patient samples and iPSC technology will advance AD drug development and patient stratification. CAMBRIDGE / EDINBURGH and ALDERLEY PARK, UK: Axol Bioscience Ltd. (Axol), a leading pluripotent stem cell technology provider for drug discovery has signed an exclusive agreement with StrataStem to access and commercialize its extensive collection of Alzheimer’s […]
CARLSBAD, Calif. — ChromaCode, a genomics multiplexing platform company developing accessible and affordable solutions for laboratories, patients and physicians, today announced a strategic investment from corporate venture capital fund Shimadzu Future Innovation Fund L.P., with general partner Global Brain Corporation. This funding will support ChromaCode’s continued development of its HDPCR technology to deliver high quality, faster, […]
Vizgen Intends to Aggressively Defend Pioneering MERSCOPE Technology in Europe Just as it has in the U.S. Previous 10x Judgments Versus Competitors Have No Application to Vizgen Cases CAMBRIDGE, Mass. —-Vizgen, Inc. (“Vizgen” or the “Company”), a life science leader dedicated to improving human health by visualizing single-cell spatial genomics information, today issued the below […]
On May 19, Shimadzu Corporation has invested in ChromaCode Inc. (ChromaCode), a startup with technology to expand genetic testing, through its corporate venture capital (CVC) fund, Shimadzu Future Innovation Fund L.P. (Shimadzu FIF). This is Shimadzu FIF’s first investment. ChromaCode is a startup that expands the number of target genes available in existing PCR with […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced the release of the enhanced xCELLigence RTCA Software Pro Version 2.8, an integrated software package for running and analyzing real-time cell analysis data. This improved version enables Agilent xCELLigence Real-Time Cell Analysis (RTCA) systems in GMP-regulated facilities. The xCELLigence RTCA Software Pro enables data integrity controls […]
SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the commercial release of new kits for its Ionic® Purification System featuring new chemistry for nucleic acid extraction from formalin-fixed paraffin-embedded (FFPE) and tumor tissue. These products offer potential improvements in quality and yield of nucleic acid extracted from complex biological samples including those with low […]
Appoints Eliot M. Lurier, CPA, as Interim Chief Financial Officer Reaffirms 2023 Financial Guidance BOULDER, Colo. — SomaLogic, Inc. (Nasdaq: SLGC), a leader in proteomics technology, today announced a Chief Financial Officer transition. Eliot M. Lurier, CPA, is joining the company as Interim CFO while the Company conducts a search for a permanent CFO. Shaun […]
Cambridge, UK: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced that it has appointed Dr. Samantha Macro as Chief Financial Officer. Samantha joins CEO, Dr Paul Brooks, on the executive team to guide all key commercial and strategic initiatives, drive revenue and shape CN Bio’s ongoing […]
LINCOLN, NE. — Neogen® Corporation (NASDAQ: NEOG) announced today that it has launched Igenity® BeefXDairy, a new and novel leading genomic test for beef-on-dairy calves. Genetic testing is critical to the efficient management and marketing of beef-on-dairy cattle, and the new Igenity BeefXDairy test provides producers with insight into key traits such as carcass quality, average […]
Proteologix to receive in-kind products and services to develop treatments for autoimmune/inflammatory diseases and oncology indications Experts from the company‘s Emprove® team and M Lab™ Collaboration Center to provide consultation and training Company has awarded grants to nearly 40 biotechnology companies since 2014 Burlington, Massachusetts – MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
